These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1884556)

  • 21. Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma.
    Levine AS; Appelbaum FR; Graw RG; Magrath IT; Pizzo PA; Poplack DG; Ziegler JL
    Cancer Treat Rep; 1978 Feb; 62(2):247-50. PubMed ID: 346213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient neurological disturbances induced by the chemotherapy of high-dose methotrexate for osteogenic sarcoma.
    Kiu MC; Liaw CC; Yang TS; Lai GM; Hsi SN; Lu CS
    Anticancer Drugs; 1994 Aug; 5(4):480-2. PubMed ID: 7949255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current therapies in osteosarcoma.
    Handelsman H; Carter SK
    Cancer Treat Rev; 1975 Mar; 2(1):77-83. PubMed ID: 1102086
    [No Abstract]   [Full Text] [Related]  

  • 24. [Controlled ultra-high dosage methotrexate therapy in three patients with metastatic osteosarcoma (author's transl)].
    Leber H; Kotz R; Chiari K; Endler T; Gabl F; Krisch K; Salzer-Kuntschik M
    Wien Klin Wochenschr; 1981 Apr; 93(7):236-40. PubMed ID: 7020262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteogenic sarcoma: advances in treatment.
    Jaffe N; Frei E
    CA Cancer J Clin; 1976; 26(6):351-9. PubMed ID: 825200
    [No Abstract]   [Full Text] [Related]  

  • 26. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid.
    Cohen IJ
    Pediatr Hematol Oncol; 2003 Dec; 20(8):579-81. PubMed ID: 14578026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter: Methotrexate-citrovorum factor in treating osteogenic sarcoma.
    Djerassi I
    N Engl J Med; 1975 May; 292(21):1133-4. PubMed ID: 1079317
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemotherapy for osteogenic sarcoma: an investigative method, not a recipe.
    Rosen G; Nirenberg A
    Cancer Treat Rep; 1982 Sep; 66(9):1687-97. PubMed ID: 6981454
    [No Abstract]   [Full Text] [Related]  

  • 29. [H-MTX-CF treatment and osteogenic sarcoma (author's transl)].
    Goto M
    Hokkaido Igaku Zasshi; 1981 Mar; 56(2):235. PubMed ID: 6976923
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
    Rosenburg SA; Chabner BA; Young RC; Seipp CA; Levine AS; Costa J; Hanson TA; Head GC; Simon RM
    Cancer Treat Rep; 1979 May; 63(5):739-51. PubMed ID: 313245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate revisited.
    Frei E
    Med Pediatr Oncol; 1976; 2(3):227-41. PubMed ID: 790144
    [No Abstract]   [Full Text] [Related]  

  • 32. [The results of using high-dose methotrexate in treating osteogenic sarcoma].
    Perevodchikova NI; Eremina LA; Manziuk LV; Siniukov PA; Fedenko AN; Singin AS; Moldovanova LK
    Vopr Onkol; 1990; 36(6):667-71. PubMed ID: 2378085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy of osteosarcoma [proceedings].
    Bleehen NM
    Proc R Soc Med; 1976 Aug; 69(8):552. PubMed ID: 1086477
    [No Abstract]   [Full Text] [Related]  

  • 34. Osteogenic sarcoma studies by the Cancer and Leukemia Group B.
    Cortes EP; Holland JF; Glidewell O
    Natl Cancer Inst Monogr; 1981 Apr; (56):207-9. PubMed ID: 7029290
    [No Abstract]   [Full Text] [Related]  

  • 35. High-dose methotrexate with a safe rescue program.
    Decker DA; Edmonson JH; Gilchrist GS; Kovach JS; Offord JR; Taylor WF
    Oncology; 1981; 38(5):262-4. PubMed ID: 6973732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Management of the administration of leucovorin calcium in high-dose methotrexate therapy].
    Kickinger W; Ritschl P; Kotz R
    Arzneimittelforschung; 1989 Jun; 39(6):728-31. PubMed ID: 2789050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Rescue" techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment.
    Bertino JR
    Semin Oncol; 1977 Jun; 4(2):203-16. PubMed ID: 301662
    [No Abstract]   [Full Text] [Related]  

  • 38. [The application of intraarterial chemotherapy for the treatment of osteogenic sarcoma in children].
    Glukhovskaia IIu
    Klin Khir; 1997; (2):12-4. PubMed ID: 9424277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy for osteosarcoma.
    Pratt CB; Rivera G; Shanks E; Kumar AP; Green AA; George S
    Cancer Treat Rep; 1978 Feb; 62(2):251-7. PubMed ID: 346214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients.
    Evans WE; Pratt CB; Taylor RH; Barker LF; Crom WR
    Cancer Chemother Pharmacol; 1979; 3(3):161-6. PubMed ID: 316744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.